Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators

Volume 321:406-412		August 10, 1989		Number 6

Add to Personal Archive

Add to Citation Manager

Notify a Friend

E-mail When Cited

PubMed Citation

Abstract

The occurrence of ventricular premature depolarizations in survivors of myocardial infarction is a risk factor for subsequent sudden death, but whether antiarrhythmic therapy reduces the risk is not known. The Cardiac Arrhythmia Suppression Trial (CAST) is evaluating the effect of antiarrhythmic therapy (encainide, flecainide, or moricizine) in patients with asymptomatic or mildly symptomatic ventricular arrhythmia (six or more ventricular premature beats per hour) after myocardial infarction. As of March 30, 1989, 2309 patients had been recruited for the initial drug-titration phase of the study: 1727 (75 percent) had initial suppression of their arrhythmia (as assessed by Holter recording) through the use of one of the three study drugs and had been randomly assigned to receive active drug or placebo. During an average of 10 months of follow-up, the patients treated with active drug had a higher rate of death from arrhythmia than the patients assigned to placebo. Encainide and flecainide accounted for the excess of deaths from arrhythmia and nonfatal cardiac arrests (33 of 730 patients taking encainide or flecainide [4.5 percent]; 9 of 725 taking placebo [1.2 percent]; relative risk, 3.6; 95 percent confidence interval, 1.7 to 8.5). They also accounted for the higher total mortality (56 of 730 [7.7 percent] and 22 of 725 [3.0 percent], respectively; relative risk, 2.5; 95 percent confidence interval, 1.6 to 4.5). Because of these results, the part of the trial involving encainide and flecainide has been discontinued. We conclude that neither encainide nor flecainide should be used in the treatment of patients with asymptomatic or minimally symptomatic ventricular arrhythmia after myocardial infarction, even though these drugs may be effective initially in suppressing ventricular arrhythmia. Whether these results apply to other patients who might be candidates for antiarrhythmic therapy is unknown.

This article has been cited by other articles:

Lu, Y., Zhang, Y., Shan, H., Pan, Z., Li, X., Li, B., Xu, C., Zhang, B., Zhang, F., Dong, D., Song, W., Qiao, G., Yang, B. (2009). MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection. Cardiovasc Res 84: 434-441 [Abstract] [Full Text]
Bach, D. S. (2009). Angiotensin-converting enzyme inhibitor therapy at the time of coronary artery bypass surgery when a friend turns mean-spirited.. J Am Coll Cardiol 54: 1785-1786 [Full Text]
Fosbol, E. L., Gislason, G. H., Poulsen, H. E., Hansen, M. L., Folke, F., Schramm, T. K., Olesen, J. B., Bretler, D.-M., Abildstrom, S. Z., Sorensen, R., Hvelplund, A., Kober, L., Torp-Pedersen, C. (2009). Prognosis in Heart Failure and the Value of {beta}-Blockers Are Altered by the Use of Antidepressants and Depend on the Type of Antidepressants Used. Circ Heart Fail 2: 582-590 [Abstract] [Full Text]
Foley, P. W.X., Leyva, F., Frenneaux, M. P. (2009). What is treatment success in cardiac resynchronization therapy?. Europace 11: v58-v65 [Abstract] [Full Text]
Gersh, B. J., Simari, R. D., Behfar, A., Terzic, C. M., Terzic, A. (2009). Cardiac Cell Repair Therapy: A Clinical Perspective. Mayo Clin Proc. 84: 876-892 [Abstract] [Full Text]
Piccini, J. P., Hasselblad, V., Peterson, E. D., Washam, J. B., Califf, R. M., Kong, D. F. (2009). Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.. J Am Coll Cardiol 54: 1089-1095 [Abstract] [Full Text]
Chan, P. S., Nallamothu, B. K., Oral, H. (2009). Amiodarone or dronedarone for atrial fibrillation: too early to know the winner?. J Am Coll Cardiol 54: 1096-1098 [Full Text]
Swedberg, K. (2009). Fallacies in clinical cardiovascular trials. Heart 95: 1464-1468 [Full Text]
Myerburg, R. J., Reddy, V., Castellanos, A. (2009). Indications for implantable cardioverter-defibrillators based on evidence and judgment.. J Am Coll Cardiol 54: 747-763 [Abstract] [Full Text]
Lindsay, B. D. (2009). Eliminating triggers of ventricular fibrillation: the past, present, and future.. J Am Coll Cardiol 54: 529-530 [Full Text]
Crandall, M. A., Bradley, D. J., Packer, D. L., Asirvatham, S. J. (2009). Contemporary Management of Atrial Fibrillation: Update on Anticoagulation and Invasive Management Strategies. Mayo Clin Proc. 84: 643-662 [Abstract] [Full Text]
Bhar-Amato, J. (2009). Fast and Furious. BMJ 339: b2339-b2339 [Full Text]
Cevik, C., Perez-Verdia, A., Nugent, K. (2009). Implantable cardioverter defibrillators and their role in heart failure progression. Europace 11: 710-715 [Abstract] [Full Text]
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53: e1-e90 [Full Text]
Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53: 1343-1382 [Full Text]
2009 WRITING GROUP TO REVIEW NEW EVIDENCE AND UPDA, , Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation 119: 1977-2016 [Full Text]
2005 WRITING COMMITTEE MEMBERS, , Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation 119: e391-e479 [Full Text]
Sato, D., Xie, L.-H., Sovari, A. A., Tran, D. X., Morita, N., Xie, F., Karagueuzian, H., Garfinkel, A., Weiss, J. N., Qu, Z. (2009). Synchronization of chaotic early afterdepolarizations in the genesis of cardiac arrhythmias. Proc. Natl. Acad. Sci. USA 106: 2983-2988 [Abstract] [Full Text]
Krumholz, H. M. (2009). Questioning Conventional Wisdom. Circ Cardiovasc Qual Outcomes 2: 59-60 [Full Text]
Koplan, B. A., Stevenson, W. G. (2009). Ventricular Tachycardia and Sudden Cardiac Death. Mayo Clin Proc. 84: 289-297 [Abstract] [Full Text]
Ghali, W. A, Rodondi, N. (2009). HDL cholesterol and cardiovascular risk. BMJ 338: a3065-a3065 [Full Text]
Eckardt, L., Breithardt, G&#x.;n., Hohnloser, S. (2009). CHAPTER 30 Ventricular Tachycardia and Sudden Cardiac Death. ESC Textbook of Cardiovascular Medicine 2: med-9780199566990-chapter-med-9780199566990-chapter [Abstract] [Full Text]
Myerburg, R. J. (2008). Implantable Cardioverter-Defibrillators after Myocardial Infarction. NEJM 359: 2245-2253 [Full Text]
Spertus, J. A. (2008). Evolving Applications for Patient-Centered Health Status Measures. Circulation 118: 2103-2110 [Abstract] [Full Text]
O'Connor, C. M., Jiang, W., Kuchibhatla, M., Mehta, R. H., Clary, G. L., Cuffe, M. S., Christopher, E. J., Alexander, J. D., Califf, R. M., Krishnan, R. R. (2008). Antidepressant Use, Depression, and Survival in Patients With Heart Failure. Arch Intern Med 168: 2232-2237 [Abstract] [Full Text]
Authors/Task Force Members, , Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J.V., Ponikowski, P., Poole-Wilson, P. A., Stromberg, A., van Veldhuisen, D. J., Atar, D., Hoes, A. W., Keren, A., Mebazaa, A., Nieminen, M., Priori, S. G., Swedberg, K., ESC Committee for Practice Guidelines (CPG), , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., Document Reviewers, , Tendera, M., Auricchio, A., Bax, J., Bohm, M., Corra, U., della Bella, P., Elliott, P. M., Follath, F., Gheorghiade, M., Hasin, Y., Hernborg, A., Jaarsma, T., Komajda, M., Kornowski, R., Piepoli, M., Prendergast, B., Tavazzi, L., Vachiery, J.-L., Verheugt, F. W. A., Zamorano, J. L., Zannad, F. (2008). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29: 2388-2442 [Full Text]
Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J.V., Ponikowski, P., Poole-Wilson, P. A., Stromberg, A., van Veldhuisen, D. J., Atar, D., Hoes, A. W., Keren, A., Mebazaa, A., Nieminen, M., Priori, S. G., Swedberg, K. (2008). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10: 933-989 [Full Text]
Comtois, P., Sakabe, M., Vigmond, E. J., Munoz, M., Texier, A., Shiroshita-Takeshita, A., Nattel, S. (2008). Mechanisms of atrial fibrillation termination by rapidly unbinding Na+ channel blockers: insights from mathematical models and experimental correlates. Am. J. Physiol. Heart Circ. Physiol. 295: H1489-H1504 [Abstract] [Full Text]
Goldberger, J. J., Cain, M. E., Hohnloser, S. H., Kadish, A. H., Knight, B. P., Lauer, M. S., Maron, B. J., Page, R. L., Passman, R. S., Siscovick, D., Stevenson, W. G., Zipes, D. P. (2008). American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. J Am Coll Cardiol 52: 1179-1199 [Full Text]
Goldberger, J. J., Cain, M. E., Hohnloser, S. H., Kadish, A. H., Knight, B. P., Lauer, M. S., Maron, B. J., Page, R. L., Passman, R. S., Siscovick, D., Stevenson, W. G., Zipes, D. P. (2008). American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Circulation 118: 1497-1518 [Full Text]
Sacher, F., Tedrow, U. B., Field, M. E., Raymond, J.-M., Koplan, B. A., Epstein, L. M., Stevenson, W. G. (2008). Ventricular Tachycardia Ablation: Evolution of Patients and Procedures Over 8 Years. Circ Arrhythm Electrophysiol 1: 153-161 [Abstract] [Full Text]
Groh, W. J., Groh, M. R., Saha, C., Kincaid, J. C., Simmons, Z., Ciafaloni, E., Pourmand, R., Otten, R. F., Bhakta, D., Nair, G. V., Marashdeh, M. M., Zipes, D. P., Pascuzzi, R. M. (2008). Electrocardiographic Abnormalities and Sudden Death in Myotonic Dystrophy Type 1. NEJM 358: 2688-2697 [Abstract] [Full Text]
Lassere, M. N (2008). The Biomarker-Surrogacy Evaluation Schema: a review of the biomarker-surrogate literature and a proposal for a criterion-based, quantitative, multidimensional hierarchical levels of evidence schema for evaluating the status of biomarkers as surrogate endpoints. Stat Methods Med Res 17: 303-340 [Abstract]
Steg, P. G., Marre, M. (2008). Does PERISCOPE Provide a New Perspective on Diabetic Treatment?. JAMA 299: 1603-1604 [Full Text]
Wellens, H. J. (2008). Forty Years of Invasive Clinical Electrophysiology: 1967-2007. Circ Arrhythm Electrophysiol 1: 49-53 [Full Text]
Au, D. H (2008). Use of {beta} blockers in patients with COPD. Thorax 63: 296-298 [Full Text]
Kawabata, M., Hirao, K., Higuchi, K., Sasaki, T., Furukawa, T., Okada, H., Hachiya, H., Isobe, M. (2008). Clinical and electrophysiological characteristics of patients having atrial flutter with 1:1 atrioventricular conduction. Europace 10: 284-288 [Abstract] [Full Text]
Venetucci, L. A., Trafford, A. W., O'Neill, S. C., Eisner, D. A. (2008). The sarcoplasmic reticulum and arrhythmogenic calcium release. Cardiovasc Res 77: 285-292 [Abstract] [Full Text]
Levy, J. H., Tanaka, K. A., Bailey, J. M. (2008). Cardiac Surgical Pharmacology. Card Surg Adult 3: 77-110 [Full Text]
Spotnitz, H. M. (2008). Surgical Implantation of Pacemakers and Automatic Defibrillators. Card Surg Adult 3: 1395-1428 [Full Text]
Lin, J. W., Garber, L., Qi, Y. R., Chang, M. G., Cysyk, J., Tung, L. (2008). Region of slowed conduction acts as core for spiral wave reentry in cardiac cell monolayers. Am. J. Physiol. Heart Circ. Physiol. 294: H58-H65 [Abstract] [Full Text]
Noujaim, S. F., Berenfeld, O., Kalifa, J., Cerrone, M., Nanthakumar, K., Atienza, F., Moreno, J., Mironov, S., Jalife, J. (2007). Universal scaling law of electrical turbulence in the mammalian heart. Proc. Natl. Acad. Sci. USA 104: 20985-20989 [Abstract] [Full Text]
Koistinen, J., Valtonen, M., Savola, J., Airaksinen, J. (2007). Thoracoscopic microwave ablation of atrial fibrillation. ICVTS 6: 695-698 [Abstract] [Full Text]
London, B., Michalec, M., Mehdi, H., Zhu, X., Kerchner, L., Sanyal, S., Viswanathan, P. C., Pfahnl, A. E., Shang, L. L., Madhusudanan, M., Baty, C. J., Lagana, S., Aleong, R., Gutmann, R., Ackerman, M. J., McNamara, D. M., Weiss, R., Dudley, S. C. Jr (2007). Mutation in Glycerol-3-Phosphate Dehydrogenase 1-Like Gene (GPD1-L) Decreases Cardiac Na+ Current and Causes Inherited Arrhythmias. Circulation 116: 2260-2268 [Abstract] [Full Text]
Aydin, O., Becker, R., Kraft, P., Voss, F., Koch, M., Kelemen, K., Katus, H. A., Bauer, A. (2007). Effects of protein kinase C activation on cardiac repolarization and arrhythmogenesis in Langendorff-perfused rabbit hearts. Europace 9: 1094-1098 [Abstract] [Full Text]
Lujan, H. L., Kramer, V. J., DiCarlo, S. E. (2007). Sex influences the susceptibility to reperfusion-induced sustained ventricular tachycardia and beta-adrenergic receptor blockade in conscious rats. Am. J. Physiol. Heart Circ. Physiol. 293: H2799-H2808 [Abstract] [Full Text]
Mark, D. B (2007). Percutaneous coronary revascularisation: is it ever worth what it costs?. Heart 93: 1161-1163 [Full Text]
Burashnikov, A., Di Diego, J. M., Zygmunt, A. C., Belardinelli, L., Antzelevitch, C. (2007). Atrium-Selective Sodium Channel Block as a Strategy for Suppression of Atrial Fibrillation: Differences in Sodium Channel Inactivation Between Atria and Ventricles and the Role of Ranolazine. Circulation 116: 1449-1457 [Abstract] [Full Text]
Hohnloser, S. H., Prystowsky, E. N. (2007). CRT-D use in heart failure: too little or too much?. Eur Heart J Suppl 9: G9-G16 [Abstract] [Full Text]
Obuchowski, N. A., Schoenhagen, P., Modic, M. T., Meziane, M., Budd, G. T. (2007). Incidence of Advanced Symptomatic Disease as Primary Endpoint in Screening and Prevention Trials. Am. J. Roentgenol. 189: 19-23 [Abstract] [Full Text]
Wittes, J., Barrett-Connor, E., Braunwald, E., Chesney, M., Cohen, H. J., DeMets, D., Dunn, L., Dwyer, J., Heaney, R. P., Vogel, V., Walters, L., Yusuf, S. (2007). Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board. Clin Trials 4: 218-234 [Abstract]
Patel, J., Heywood, J. T. (2007). Mode of Death in Patients With Systolic Heart Failure. J CARDIOVASC PHARMACOL THER 12: 127-136 [Abstract]
Stokoe, K. S., Balasubramaniam, R., Goddard, C. A., Colledge, W. H., Grace, A. A., Huang, C. L.-H. (2007). Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/ murine hearts modelling the Brugada syndrome. J. Physiol. 581: 255-275 [Abstract] [Full Text]
Khavandi, A, Walker, P R (2007). Flecainide cardiotoxicity precipitated by electrolyte imbalance. Caution with thiazide diuretics. Emerg. Med. J. 24: e26-e26 [Abstract] [Full Text]
Nattel, S., Maguy, A., Le Bouter, S., Yeh, Y.-H. (2007). Arrhythmogenic Ion-Channel Remodeling in the Heart: Heart Failure, Myocardial Infarction, and Atrial Fibrillation. Physiol. Rev. 87: 425-456 [Abstract] [Full Text]
Bauer, A., Becker, R., Dreyhaupt, J., Voss, F., Kraft, P., Kelemen, K., Senges-Becker, J. C., Katus, H. A., Schoels, W. (2007). Role of KATP channels in repetitive induction of ventricular fibrillation. Europace 9: 154-161 [Abstract] [Full Text]
Jensen, G. B., Hampton, J. (2007). Early termination of drug trials. BMJ 334: 326-326 [Full Text]
Cooper, C. J., Murphy, T. P. (2007). The Case for Renal Artery Stenting for Treatment of Renal Artery Stenosis. Circulation 115: 263-270 [Full Text]
Den Ruijter, H. M., Berecki, G., Opthof, T., Verkerk, A. O., Zock, P. L., Coronel, R. (2007). Pro- and antiarrhythmic properties of a diet rich in fish oil. Cardiovasc Res 73: 316-325 [Abstract] [Full Text]
Dzau, V. J., Antman, E. M., Black, H. R., Hayes, D. L., Manson, J. E., Plutzky, J., Popma, J. J., Stevenson, W. (2006). The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part II: Clinical Trial Evidence (Acute Coronary Syndromes Through Renal Disease) and Future Directions. Circulation 114: 2871-2891 [Full Text]
Ikeda, T., Yoshino, H., Sugi, K., Tanno, K., Shimizu, H., Watanabe, J., Kasamaki, Y., Yoshida, A., Kato, T. (2006). Predictive Value of Microvolt T-Wave Alternans for Sudden Cardiac Death in Patients With Preserved Cardiac Function After Acute Myocardial Infarction: Results of a Collaborative Cohort Study. J Am Coll Cardiol 48: 2268-2274 [Abstract] [Full Text]
Finch, S. J., van Zyl, L. T. (2006). Cardioversion of Persistent Atrial Arrhythmia After Treatment With Venlafaxine in Successful Management of Major Depression and Posttraumatic Stress Disorder. Psychosomatics 47: 533-536 [Abstract] [Full Text]
Barzilay, J. I., Davis, B. R., Cutler, J. A., Pressel, S. L., Whelton, P. K., Basile, J., Margolis, K. L., Ong, S. T., Sadler, L. S., Summerson, J., for the ALLHAT Collaborative Research Group, (2006). Fasting Glucose Levels and Incident Diabetes Mellitus in Older Nondiabetic Adults Randomized to Receive 3 Different Classes of Antihypertensive Treatment: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).. Arch Intern Med 166: 2191-2201 [Abstract] [Full Text]
Ng, G A. (2006). Treating patients with ventricular ectopic beats.. Heart 92: 1707-1712 [Full Text]
Tan, B.-H., Valdivia, C. R., Song, C., Makielski, J. C. (2006). Partial expression defect for the SCN5A missense mutation G1406R depends on splice variant background Q1077 and rescue by mexiletine. Am. J. Physiol. Heart Circ. Physiol. 291: H1822-H1828 [Abstract] [Full Text]
Developed in Collaboration With the European Heart, , Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quinones, M. A., Roden, D. M., Silka, M. J., Tracy, C., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Antman, E. M., Anderson, J. L., Hunt, S. A., Halperin, J. L., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L. (2006). ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 48: e247-e346 [Full Text]
Writing Committee Members, , Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quinones, M. A., Roden, D. M., Silka, M. J., Tracy, C., ESC Committee for Practice Guidelines, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L., ACC/AHA Task Force Members, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Antman, E. M., Anderson, J. L., Hunt, S. A., Halperin, J. L., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B. (2006). ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 8: 746-837 [Full Text]
Granger, C. B., McMurray, J. J.V. (2006). Using Measures of Disease Progression to Determine Therapeutic Effect: A Sirens' Song. J Am Coll Cardiol 48: 434-437 [Abstract] [Full Text]
Cohn, J. N. (2006). Efficacy and Safety in Clinical Trials in Cardiovascular Disease. J Am Coll Cardiol 48: 430-433 [Abstract] [Full Text]
Boyle, A. J., Schulman, S. P., Hare, J. M. (2006). Stem Cell Therapy for Cardiac Repair: Ready for the Next Step. Circulation 114: 339-352 [Full Text]
Kesselheim, A. S., Fischer, M. A., Avorn, J. (2006). The rise and fall of Natrecor for congestive heart failure: implications for drug policy.. Health Aff (Millwood) 25: 1095-1102 [Abstract] [Full Text]
Tardif, J.-C., Heinonen, T., Orloff, D., Libby, P. (2006). Vascular Biomarkers and Surrogates in Cardiovascular Disease. Circulation 113: 2936-2942 [Abstract] [Full Text]
Verkerk, A. O., van Ginneken, A. C.G., Berecki, G., den Ruijter, H. M., Schumacher, C. A., Veldkamp, M. W., Baartscheer, A., Casini, S., Opthof, T., Hovenier, R., Fiolet, J. W.T., Zock, P. L., Coronel, R. (2006). Incorporated sarcolemmal fish oil fatty acids shorten pig ventricular action potentials. Cardiovasc Res 70: 509-520 [Abstract] [Full Text]
Weiss, J. N., Karma, A., Shiferaw, Y., Chen, P.-S., Garfinkel, A., Qu, Z. (2006). From Pulsus to Pulseless: The Saga of Cardiac Alternans. Circ. Res. 98: 1244-1253 [Abstract] [Full Text]
Roth-Cline, M. D. (2006). Clinical Trials in the Wake of Vioxx: Requiring Statistically Extreme Evidence of Benefit to Ensure the Safety of New Drugs. Circulation 113: 2253-2259 [Full Text]
Society for Clinical Trials Board of Directors, (2006). The Society for Clinical Trials opposes US legislation to permit marketing of unproven medical therapies for seriously ill patients. Clin Trials 3: 154-157
Enseleit, F., Duru, F. (2006). Long-term continuous external electrocardiographic recording: a review.. Europace 8: 255-266 [Abstract] [Full Text]
Cochrane, T. I., Truog, R. D., Mareiniss, D. P., Glick, S. M., Casarett, D., Kapo, J., Caplan, A. (2006). Appropriate use of artificial nutrition and hydration.. NEJM 354: 1320-1321 [Full Text]
Connolly, S. J. (2006). Use and Misuse of Surrogate Outcomes in Arrhythmia Trials. Circulation 113: 764-766 [Full Text]
Bunch, T. J., Ackerman, M. J. (2006). Promoting Arrhythmia Susceptibility. Circulation 113: 330-332 [Full Text]
Bezzina, C. R., Shimizu, W., Yang, P., Koopmann, T. T., Tanck, M. W.T., Miyamoto, Y., Kamakura, S., Roden, D. M., Wilde, A. A.M. (2006). Common Sodium Channel Promoter Haplotype in Asian Subjects Underlies Variability in Cardiac Conduction. Circulation 113: 338-344 [Abstract] [Full Text]
Bito, V., Dauwe, D., Verdonck, F., Mubagwa, K., Sipido, K. R. (2006). The Amiodarone Derivative KB130015 [2-Methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran] Induces an Na+-Dependent Increase of [Ca2+] in Ventricular Myocytes. J. Pharmacol. Exp. Ther. 316: 162-168 [Abstract] [Full Text]

Comments and questions? Please contact us.